Literature DB >> 23887802

Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye disease study 2: AREDS2 report 7.

Amitha Domalpally1, Ronald P Danis, Emily Y Chew, Traci E Clemons, Susan Reed, John Paul Sangiovanni, Frederick L Ferris.   

Abstract

PURPOSE: We described the system for grading lens opacities using stereoscopic digital fundus reflex photographs in the Age-Related Eye Disease Study 2 (AREDS2) and compared reproducibility with the AREDS lens grading system, which used retroillumination film images.
METHODS: Stereoscopic fundus reflex photographs were acquired in a standardized fashion at baseline and annually. Images were enhanced and evaluated in the red channel at a central reading center. Percentage involvement of cortical and posterior subcapsular (PSC) lens opacities within the central 5 mm diameter zone of a modified AREDS lens grid was estimated. Reproducibility was assessed for contemporaneous variability (ongoing, monthly regrade on 5% of submissions, n = 777 eyes) and temporal drift (regrading a subset of baseline photographs annually, n = 88).
RESULTS: In the contemporaneous exercise, the agreement for presence of cortical opacities was 93% (κ = 0.86) and for PSC opacities it was 97% (κ = 0.83). Intraclass correlation (ICC) for area of central zone involvement was 0.95 for cortical and 0.99 for PSC opacities. Historic data for contemporaneous regrading of film-based images in AREDS showed an ICC of 0.94 for cortical and 0.82 for PSC. The final annual temporal drift exercise had a reproducibility of 95% for cortical and PSC opacities.
CONCLUSIONS: Digital grading using fundus reflex images with image enhancing tools has reproducibility comparable to film-based retroillumination images, and may be useful for centralized objective lens opacity assessment in clinical trials using widely available fundus cameras. Red reflex images limit evaluation to cortical and PSC opacities, and do not permit assessment of nuclear opacities. (ClinicalTrials.gov number, NCT00345176.).

Entities:  

Keywords:  AREDS2; cataract; lens opacity

Mesh:

Year:  2013        PMID: 23887802      PMCID: PMC3771555          DOI: 10.1167/iovs.13-12301

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  A simplified cataract grading system.

Authors:  B Thylefors; L T Chylack; K Konyama; K Sasaki; R Sperduto; H R Taylor; S West
Journal:  Ophthalmic Epidemiol       Date:  2002-04       Impact factor: 1.648

2.  A comparison of two photographic systems for grading cataract.

Authors:  H R Taylor; J A Lee; F Wang; B Muñoz
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-03       Impact factor: 4.799

3.  Cataract blindness.

Authors:  Alan L Robin; Ravilla D Thulasiraj
Journal:  Arch Ophthalmol       Date:  2012-11

4.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

5.  The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-02       Impact factor: 5.258

6.  Assessment of cataracts from photographs in the Beaver Dam Eye Study.

Authors:  B E Klein; R Klein; K L Linton; Y L Magli; M W Neider
Journal:  Ophthalmology       Date:  1990-11       Impact factor: 12.079

7.  Prevalence of cataract and pseudophakia/aphakia among adults in the United States.

Authors:  Nathan Congdon; Johannes R Vingerling; Barbara E K Klein; Sheila West; David S Friedman; John Kempen; Benita O'Colmain; Suh-Yuh Wu; Hugh R Taylor
Journal:  Arch Ophthalmol       Date:  2004-04

Review 8.  The detection and grading of cataract: an epidemiologic perspective.

Authors:  S K West; H R Taylor
Journal:  Surv Ophthalmol       Date:  1986 Nov-Dec       Impact factor: 6.048

9.  Validation of methods for the assessment of cataract progression in the Roche European-American Anticataract Trial (REACT)

Authors:  L T Chylack; J K Wolfe; J Friend; W Tung; D M Singer; N P Brown; M A Hurst; W Köpcke; W Schalch
Journal:  Ophthalmic Epidemiol       Date:  1995-06       Impact factor: 1.648

10.  Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.

Authors:  Emily Y Chew; John Paul SanGiovanni; Frederick L Ferris; Wai T Wong; Elvira Agron; Traci E Clemons; Robert Sperduto; Ronald Danis; Suresh R Chandra; Barbara A Blodi; Amitha Domalpally; Michael J Elman; Andrew N Antoszyk; Alan J Ruby; David Orth; Susan B Bressler; Gary E Fish; George B Hubbard; Michael L Klein; Thomas R Friberg; Philip J Rosenfeld; Cynthia A Toth; Paul Bernstein
Journal:  JAMA Ophthalmol       Date:  2013-07       Impact factor: 7.389

View more
  3 in total

1.  A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.

Authors:  Freekje van Asten; Michael Simmons; Ayush Singhal; Tiarnan D Keenan; Rinki Ratnapriya; Elvira Agrón; Traci E Clemons; Anand Swaroop; Zhiyong Lu; Emily Y Chew
Journal:  Ophthalmology       Date:  2017-10-31       Impact factor: 12.079

2.  Association between polymorphisms of OGG1, EPHA2 and age-related cataract risk: a meta-analysis.

Authors:  Hongxu Zhang; Jianguang Zhong; Zhenyu Bian; Xiang Fang; You Peng; Yongping Hu
Journal:  BMC Ophthalmol       Date:  2016-09-29       Impact factor: 2.209

3.  Imaging of Age-Related Macular Degeneration by Adaptive Optics Scanning Laser Ophthalmoscopy in Eyes With Aged Lenses or Intraocular Lenses.

Authors:  Yuhua Zhang; Xiaolin Wang; Mark E Clark; Christine A Curcio; Cynthia Owsley
Journal:  Transl Vis Sci Technol       Date:  2020-07-29       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.